Published in Adv Virol on May 16, 2011
The human respiratory syncytial virus matrix protein is required for maturation of viral filaments. J Virol (2012) 1.03
The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics. J Virol (2013) 1.01
Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses (2014) 0.89
The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism. J Virol (2013) 0.87
Modulation of host adaptive immunity by hRSV proteins. Virulence (2014) 0.78
Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design. Immunology (2014) 0.77
Respiratory Syncytial Virus and Cellular Stress Responses: Impact on Replication and Physiopathology. Viruses (2016) 0.77
Molecular mechanisms driving respiratory syncytial virus assembly. Future Microbiol (2013) 0.77
RSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membrane. Nat Commun (2017) 0.75
A guided tour into subcellular colocalization analysis in light microscopy. J Microsc (2006) 16.73
Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J (2004) 7.62
Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J Cell Sci (1992) 4.64
Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol (1983) 4.05
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A (1985) 3.93
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc Natl Acad Sci U S A (1984) 3.42
Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc Natl Acad Sci U S A (1996) 3.39
Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol (1987) 2.79
Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology (2001) 2.38
Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol (2002) 2.02
Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J Virol (1998) 1.95
Neonatal respiratory syncytial virus infection. N Engl J Med (1979) 1.82
Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol (1995) 1.73
Function of the respiratory syncytial virus small hydrophobic protein. J Virol (2007) 1.64
Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol (2006) 1.52
Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol (2006) 1.40
Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology (2004) 1.34
Nucleotide sequence of the gene encoding respiratory syncytial virus matrix protein. J Virol (1984) 1.31
Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol J (2007) 1.30
Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J Gen Virol (2002) 1.22
The 1A protein gene of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polycistronic transcript. Virology (1985) 1.20
The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J Virol (2006) 1.20
Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J Gen Virol (2002) 1.20
Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J Gen Virol (2005) 1.19
Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol (2009) 1.17
Respiratory syncytial virus infection in older persons. Vaccine (1998) 1.09
The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol J (2008) 1.05
Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein. J Virol (2003) 1.05
Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses. Virology (1992) 1.01
Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability. FEBS Lett (2010) 1.00
The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins. J Virol (2004) 0.97
The RSV F and G glycoproteins interact to form a complex on the surface of infected cells. Biochem Biophys Res Commun (2007) 0.94
The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen-activated protein kinase p38-dependent tyrosine kinase activity during virus infection. J Gen Virol (2005) 0.94
Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex. Arch Virol (2001) 0.92
Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells. J Virol (2008) 0.91
trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission. J Virol (2004) 0.88
Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science (2006) 3.70
Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus. Biochim Biophys Acta (2002) 1.49
Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome. Proc Natl Acad Sci U S A (2002) 1.39
Segment-specific terminal sequences of Bunyamwera bunyavirus regulate genome replication. Virology (2003) 1.38
Bunyamwera bunyavirus RNA synthesis requires cooperation of 3'- and 5'-terminal sequences. J Virol (2004) 1.30
The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J Virol (2006) 1.20
Role of the conserved nucleotide mismatch within 3'- and 5'-terminal regions of Bunyamwera virus in signaling transcription. J Virol (2005) 1.17
Identification of the Bunyamwera bunyavirus transcription termination signal. J Gen Virol (2006) 1.08
Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages. J Virol (2004) 1.07
Identification of an upstream sequence element required for vesicular stomatitis virus mRNA transcription. J Virol (2002) 1.00
The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins. J Virol (2004) 0.97
Mutations in the C-terminal loop of the nucleocapsid protein affect vesicular stomatitis virus RNA replication and transcription differentially. J Virol (2009) 0.97
Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host. J Virol (2003) 0.97
Analysis of a structural homology model of the 2'-O-ribose methyltransferase domain within the vesicular stomatitis virus L protein. Virology (2008) 0.95
The Bunyamwera virus mRNA transcription signal resides within both the 3' and the 5' terminal regions and allows ambisense transcription from a model RNA segment. J Virol (2005) 0.95
Variations in intergenic region sequences of Human respiratory syncytial virus clinical isolates: analysis of effects on transcriptional regulation. Virology (2004) 0.94
Vesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice. J Virol (2003) 0.92
Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells. J Virol (2008) 0.91
S-adenosyl homocysteine-induced hyperpolyadenylation of vesicular stomatitis virus mRNA requires the methyltransferase activity of L protein. J Virol (2008) 0.90
The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein. Vaccine (2007) 0.88
trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission. J Virol (2004) 0.88
Transcriptional termination modulated by nucleotides outside the characterized gene end sequence of respiratory syncytial virus. Virology (2002) 0.87
Identification of a single amino acid change in the human respiratory syncytial virus L protein that affects transcriptional termination. J Virol (2003) 0.86
Importance of hydrogen bond contacts between the N protein and RNA genome of vesicular stomatitis virus in encapsidation and RNA synthesis. J Virol (2009) 0.86
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003. Virus Res (2004) 0.85
Newly identified phosphorylation site in the vesicular stomatitis virus P protein is required for viral RNA synthesis. J Virol (2013) 0.83
Variations in transcription termination signals of human respiratory syncytial virus clinical isolates affect gene expression. Virology (2003) 0.82
Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host. Vaccine (2004) 0.82
Selection for gene junction sequences important for VSV transcription. Virology (2008) 0.81
A temperature sensitive VSV identifies L protein residues that affect transcription but not replication. Virology (2009) 0.81
Biological differences between vesicular stomatitis virus Indiana and New Jersey serotype glycoproteins: identification of amino acid residues modulating pH-dependent infectivity. J Virol (2005) 0.80
Helical virus structure: the case of the rhabdovirus bullet. Viruses (2010) 0.79
Second-site mutations selected in transcriptional regulatory sequences compensate for engineered mutations in the vesicular stomatitis virus nucleocapsid protein. J Virol (2012) 0.78